Laryssa C. Manigat

Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha

I. Nakano, E. Sulman, M. Mayo, 2018, Neuro-oncology.

Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner

T. Harris, B. Purow, T. Bullock, 2021, Journal of Neuro-Oncology.

Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms

I. Nakano, T. Abbas, N. Leitinger, 2017, Clinical Cancer Research.

Validation of Digital Pathology Platform for Metabolic-Associated Steatohepatitis for Clinical Trials

Andrew H. Beck, M. Torbenson, P. Bedossa, 2023, medRxiv.

Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma.

I. Nakano, T. Abbas, Breanna Brenneman, 2018, Cancer research.

Loss of Diacylglycerol Kinase α Enhances Macrophage Responsiveness

X. Zhong, Luke R. Vass, T. Harris, 2021, Frontiers in Immunology.

Identification of ritanserin analogs that display DGK isoform specificity.

T. Harris, M. E. Granade, Laryssa C. Manigat, 2022, Biochemical pharmacology.